A key regulatory loop AK4P1/miR-375/SP1 in pancreatic adenocarcinoma

References

• Mizrahi JD, Surana R, Valle JW, et al. Pancreatic cancer. Lancet. 2020;395(10242):2008–13.
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang X, Xu J. NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1. Nature Communications. 2021;12(1):4536.
   PubMed Web of Science ®Google Scholar
• Mohammed S, Van Buren G 2nd, Fisher WE. Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014;20:9354–9360.
   PubMed Web of Science ®Google Scholar
• Chen Z, Huang Z, Chen LX. The olfactory receptor pseudo-pseudogene: a potential therapeutic target in human diseases. BES. 2018;31(2):168–170.
   Google Scholar
• Lou W, Ding B, Fu P. Pseudogene-derived lncRNAs and their miRNA sponging mechanism in human cancer. Front Cell Dev Biol. 2020;8:85.
   PubMed Web of Science ®Google Scholar
• Hou Z, Wang Y, Xia N, et al. Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR-497-5p/mTOR. Cancer Science. 2021;112(1):275–286.
   PubMed Web of Science ®Google Scholar
• Zheng L, Li X, Gu Y, et al. The 3’UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1. Breast Cancer Res Treat. 2015;150(1):105–118.
   PubMed Web of Science ®Google Scholar
• Zheng H, Ding B, Xue K, et al. Construction of a lncRNA/pseudogene-hsa-miR-30d-5p-GJA1 regulatory network related to metastasis of pancreatic cancer. Genomics. 2021;113(4):1742–1753.
   PubMed Web of Science ®Google Scholar
• Lou W, Ding B, Fan W. High expression of pseudogene PTTG3P indicates a poor prognosis in human breast cancer. Mol Ther Oncolytics. 2019;14:15–26.
   PubMed Web of Science ®Google Scholar
• Lou W, Ding B, Zhong G, et al. Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer. Aging (Albany NY). 2019;11(23):11416–11439.
   PubMedGoogle Scholar
• Wu L, Ding Y, Tong H, et al. Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612/ Cadherin 4 axis. Cancer Cell International. 2021;21(1):392.
   PubMed Web of Science ®Google Scholar
• Ostovarpour M, Khalaj-Kondori M, Ghasemi T. Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer. Molecular Biology Reports. 2021;48(5):4581–4589.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen Y, Dong K, et al. Effects of FER1L4-miR-106a-5p/miR-372-5p-E2F1 regulatory axis on drug resistance in liver cancer chemotherapy. Mol Ther Nucleic Acids. 2021;24:449–461.
   PubMedGoogle Scholar
• Zhang N, Zeng L, Wang S. LncRNA FER1L4 promotes oral squamous cell carcinoma progression via targeting miR-133a-5p/Prx1 axis. OncoTargets and Therapy. 2021;14:795–806.
   PubMed Web of Science ®Google Scholar
• Lou W, Ding B, Zhong G, et al. RP11-480I12.5-004 promotes growth and tumorigenesis of breast cancer by relieving miR-29c-3p-Mediated AKT3 and CDK6 degradation. Mol Ther Nucleic Acids. 2020;21:916–931.
   PubMedGoogle Scholar
• Chen Z, Wang Z, Chen Z, et al. Pseudogene HSPB1P1 contributes to renal cell carcinoma proliferation and metastasis by targeting miR-296-5p to regulate HMGA1 expression. Cell Biology International. 2021;45(12):2479–2489.
   PubMed Web of Science ®Google Scholar
• Ding B, Fan W, Lou W. hsa_circ_0001955 enhances in vitro proliferation, migration, and invasion of HCC cells through miR-145-5p/NRAS axis. Mol Ther Nucleic Acids. 2020;22:445–455.
   PubMedGoogle Scholar
• Li L, Xiao C, He K. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375. IUBMB Life. 2021;73(9):1153–1165.
   PubMed Web of Science ®Google Scholar
• Ni H, Qin H, Sun C, et al. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther. 2021;12(1):325.
   PubMed Web of Science ®Google Scholar
• Zhang K, Wang Q, Zhong B, et al. LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression. Journal of Cellular and Molecular Medicine. 2021;25(10):4543–4550.
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu Z, Lin Q, et al. MiRNAs and cancer: key link in diagnosis and therapy. Genes (Basel). 2021;13(1):12.
   PubMedGoogle Scholar
• Lou W, Liu J, Gao Y, et al. MicroRNA regulation of liver cancer stem cells. Am J Cancer Res. 2018;8:1126–1141.
   PubMed Web of Science ®Google Scholar
• Vizcaíno C, Mansilla S, Portugal J. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 2015;152:111–124.
   PubMed Web of Science ®Google Scholar
• Zheng G, Chen W, Li W, et al. E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance. Biochem Biophys Res Commun. 2020;530(4):624–631.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wu J, Zhou H, et al. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A. Cell Cycle. 2020;19(12):1502–1516.
   PubMed Web of Science ®Google Scholar
• Huang JL, Cao SW, Ou QS, et al. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Mol Cancer. 2018;17(1):93.
   PubMedGoogle Scholar
• Tan H, Wu C, Huang B, et al. MiR-3666 serves as a tumor suppressor in ovarian carcinoma by down-regulating AK4 via targeting STAT3. Cancer Biomarkers. 2021;30(4):355–363.
   PubMed Web of Science ®Google Scholar
• Wu Z, Gong Q, Yu Y, et al. Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis. BMC Pulmonary Medicine. 2020;20(1):10.
   PubMed Web of Science ®Google Scholar
• Jan YH, Lai TC, Yang CJ, et al. Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis. Journal of Hematology & Oncology. 2019;12(1):12.
   PubMedGoogle Scholar
• Zhang J, Yin YT, Wu CH, et al. AK4 promotes the progression of HER2-positive breast cancer by facilitating cell proliferation and invasion. Disease Markers. 2019;2019:8186091.
   PubMed Web of Science ®Google Scholar
• Xin F, Yao DW, Fan L, et al. Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion. Clinical and Experimental Medicine. 2019;19(4):525–534.
   PubMed Web of Science ®Google Scholar
• Zheng LL, Zhou KR, Liu S, et al. dreamBase: DNA modification, RNA regulation and protein binding of expressed pseudogenes in human health and disease. Nucleic Acids Res. 2018;46(D1):D85–d91.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102.
   PubMed Web of Science ®Google Scholar
• Cao Z, Pan X, Yang Y, et al. The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics. 2018;34(13):2185–2194.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–97.
   PubMed Web of Science ®Google Scholar
• Yang JH, Li JH, Shao P, et al. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2011;39(suppl_1):D202–209.
   PubMedGoogle Scholar
• Chang L, Zhou G, Soufan O, et al. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 2020;48(W1):W244–w251.
   PubMed Web of Science ®Google Scholar
• Fan Y, Siklenka K, Arora SK, et al. miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic Acids Res. 2016;44(W1):W135–141.
   PubMed Web of Science ®Google Scholar
• Lou W, Liu J, Ding B, et al. Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer. Aging (Albany NY). 2019;11(9):2628–2652.
   PubMedGoogle Scholar